Evidence map›Paper›PMID 34359697›Full record

ArticleCancers2021

A Personal Breast Cancer Risk Stratification Model Using Common Variants and Environmental Risk Factors in Japanese Females.

Isao Oze, Hidemi Ito, Yumiko Kasugai, Taiki Yamaji, Yuko Kijima, Tomotaka Ugai, Yoshio Kasuga, Tomoyo K Ouellette, Yukari Taniyama, Yuriko N Koyanagi and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. CD8Molecular medicine reports · 2024
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Isao OzeDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.ORCID 0000-0002-0762-1147
Hidemi ItoDivision of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.ORCID 0000-0002-8023-4581
Yumiko KasugaiDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
Taiki YamajiDivision of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo 104-0045, Japan.
Yuko KijimaDepartment of Breast Surgery, School of Medicine Fujita Health University, Aichi 470-1192, Japan.
Tomotaka UgaiDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
Yoshio KasugaDepartment of Surgery, Nagano Matsushiro General Hospital, Nagano 381-1231, Japan.
Tomoyo K OuelletteKaneko Clinic, Kagoshima 890-0055, Japan.
Yukari TaniyamaDivision of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
Yuriko N KoyanagiDivision of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
Issei ImotoDirector, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.ORCID 0000-0002-4150-7938
Shoichiro TsuganeNational Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo 162-8636, Japan.ORCID 0000-0003-4105-2774
Chihaya KoriyamaDepartment of Epidemiology and Preventive Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan.
Motoki IwasakiDivision of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo 104-0045, Japan.
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.ORCID 0000-0003-1761-6314
Aichi Cancer Center · JPBrigham and Women's Hospital · USFujita Health University · JPKagoshima University · JPKaneka (Japan) · JPNagano Matsushiro General Hospital · JPNational Institute of Infectious Diseases · JP

Funding

Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan Innovative Areas 221S0001Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan Priority Areas of Cancer 17015018Japan Agency for Medical Research and Development JP17ck0106177Japan Agency for Medical Research and Development JP20ck0106553Japan Society for the Promotion of Science JP16H06277Japan Society for the Promotion of Science JP20590650
6 · The paper itself

Abstract

Personalized approaches to prevention based on genetic risk models have been anticipated, and many models for the prediction of individual breast cancer risk have been developed. However, few studies have evaluated personalized risk using both genetic and environmental factors. We developed a risk model using genetic and environmental risk factors using 1319 breast cancer cases and 2094 controls from three case-control studies in Japan. Risk groups were defined based on the number of risk alleles for 14 breast cancer susceptibility loci, namely low (0-10 alleles), moderate (11-16) and high (17+). Environmental risk factors were collected using a self-administered questionnaire and implemented with harmonization. Odds ratio (OR) and C-statistics, calculated using a logistic regression model, were used to evaluate breast cancer susceptibility and model performance. Respective breast cancer ORs in the moderate- and high-risk groups were 1.69 (95% confidence interval, 1.39-2.04) and 3.27 (2.46-4.34) compared with the low-risk group. The C-statistic for the environmental model of 0.616 (0.596-0.636) was significantly improved by combination with the genetic model, to 0.659 (0.640-0.678). This combined genetic and environmental risk model may be suitable for the stratification of individuals by breast cancer risk. New approaches to breast cancer prevention using the model are warranted.

Indexed as

breast cancerenvironmental risk modelgenetic risk modelpersonalized preventionpolygenic risk model

Identifiers

PMID34359697
PMCPMC8345053
OpenAlexW3183302134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.